FDA Governments Medical Specialties Neurology News

U.S. FDA approves GSK’s HIV drug for patients with limited options

The U.S. Food and Drug Administration on Thursday approved GlaxoSmithKline Plc’s HIV drug, Rukobia, to treat adult patients who have run out of treatment options.

Antiretroviral medicines suppress HIV and help in decreasing disease progression, HIV transmission, and AIDS-related deaths. However, HIV has the ability to constantly change and can lead to some individuals developing viral resistance, causing their treatment regimens to fail.

The most common adverse reactions from the drug, taken twice daily, were nausea, fatigue and diarrhea.

Pfizer and Shionogi & Co Ltd hold small stakes in ViiV Healthcare.

Read More

Meeta Ramnani
Meeta Ramnani
Meeta develops credible content about various markets based on deep research, opinions from experts and inputs from industry leaders. As the managing editor at Smart Industry News, she assures that every piece of news and article adds to the knowledge of decision makers. An avid bike rider, Meeta, is a postgraduate from Indian Institute of Journalism and New Media (IIJNM) Bangalore, where her specialization was Business Journalism. She carries experience from mainstream print media including The Times Group and Sakal Media Group.